ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

After tough times last year, Peregrine Pharma reaches agreement with FDA on late-stage trial for lung cancer drug

After tough times last year, Peregrine Pharma reaches agreement with FDA on late-stage trial for lung cancer drug

May 20, 2013 9:40 am by | 0 Comments

(Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug.The late-stage ... Read more

J&J’s wins ulcerative colitis indication for Simponi

J&J’s wins ulcerative colitis indication for Simponi

May 15, 2013 5:55 pm by | 0 Comments

(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.Simponi is already ... Read more


For-profit dialysis centers continued to use anemia drug after black box warning

For-profit dialysis centers continued to use anemia drug after black box warning

May 15, 2013 3:40 pm by | 0 Comments

NEW YORK (Reuters Health) - Despite a strong warning from U.S. regulators in 2007, for-profit dialysis centers still gave their kidney failure patients more of a certain anemia drug than ... Read more

What’s behind the FDA’s push for more patient engagement (hint: it’s not that everyone else is doing it)

What’s behind the FDA’s push for more patient engagement (hint: it’s not that everyone else is doing it)

May 13, 2013 11:04 am by | 0 Comments

Lately, the U.S. Food and Drug Administration seems to be doing a bit of re-branding: A new Patient Network site is anchoring a push for more patient engagement in the ... Read more

Is an Office of mHealth the best thing about the bill creating an Office of mHealth?

Is an Office of mHealth the best thing about the bill creating an Office of mHealth?

May 12, 2013 9:30 am by | 1 Comments

Version 2.0 of a plan to create an Office of mHealth in the U.S. Food and Drug Administration should be out soon. The office of U.S. Rep. Mike Honda, Silicon ... Read more

FDA allows sales of generic Opana painkiller to continue

FDA allows sales of generic Opana painkiller to continue

May 11, 2013 4:57 am by | 0 Comments

Federal regulators said Friday that they would continue to allow sales of generic Opana, a narcotic painkiller similar to OxyContin, even though the pills are prone to abuse.Like OxyContin, Opana ... Read more

FDA approves Glaxo/Theravance drug for COPD lung disease

FDA approves Glaxo/Theravance drug for COPD lung disease

May 10, 2013 11:35 am by | 0 Comments

(Reuters) - The Food and Drug Administration has approved a new drug to treat chronic obstructive pulmonary disease, a condition often associated with smoking that can include emphysema, chronic bronchitis, ... Read more


Judge criticizes FDA move on Plan B, agency warns of precedent

Judge criticizes FDA move on Plan B, agency warns of precedent

May 7, 2013 4:20 pm by | 0 Comments

NEW YORK (Reuters) - A federal judge criticized the Food and Drug Administration over its refusal to make emergency contraception available to girls of all ages without a prescription, saying ... Read more

FDA strengthens warnings on tanning beds to reduce cancer risk

FDA strengthens warnings on tanning beds to reduce cancer risk

May 6, 2013 2:33 pm by | 0 Comments

Washington (Reuters) - Tanning beds and sunlamps will be required to carry stronger warning labels under new regulations proposed by the U.S. Food and Drug Administration, which is also recommending ... Read more

FDA warns shorter name of new Roche cancer drug may cause confusion

FDA warns shorter name of new Roche cancer drug may cause confusion

May 6, 2013 11:01 am by | 0 Comments

(Reuters) - The U.S. health regulator warned on Monday that using a shorter name for Roche's new breast cancer drug Kadcyla may lead to the treatment being confused with an ... Read more

FDA approves J&J sedation drug device for use during colonscopies

FDA approves J&J sedation drug device for use during colonscopies

May 4, 2013 11:06 am by | 0 Comments

(Reuters) - U.S. regulators have approved Johnson & Johnson's Sedasys system to sedate patients during colonoscopies without the need for a physician to monitor delivery of the injectable sedating agent, ... Read more

FDA panel votes against approval of Aveo’s kidney cancer drug

FDA panel votes against approval of Aveo’s kidney cancer drug

May 2, 2013 12:12 pm by | 0 Comments

(Reuters) - Aveo Pharmaceuticals Inc and Astellas Pharma Inc have not demonstrated that the benefits of their experimental kidney cancer drug tivozanib outweighs the risk, an advisory panel to the ... Read more

Groups say FDA’s Plan B decision falls short of court order

Groups say FDA’s Plan B decision falls short of court order

May 1, 2013 2:50 pm by | 0 Comments

NEW YORK (Reuters) - Reproductive-rights groups that sued the Food and Drug Administration over access to the "morning-after" pill will ask a judge to hold the agency in contempt if ... Read more

Stifled by regulation, entrepreneurs take life-saving devices overseas

Stifled by regulation, entrepreneurs take life-saving devices overseas

April 30, 2013 10:00 am by | 0 Comments

’Uncertainty’ is not a word that Silicon Valley’s investors ’ or their limited partners ’ like to hear. Medical device entrepreneurs and entrepreneurs have complained vociferously for years that funding ... Read more

FDA looking at caffeine impact on kids after new Wrigley gum

FDA looking at caffeine impact on kids after new Wrigley gum

April 30, 2013 9:51 am by | 0 Comments

(Reuters) - Wrigley's new Alert Energy Caffeine Gum has prompted the Food and Drug Administration to look into the potential impact added caffeine may have on children and adolescents.The FDA ... Read more